Archives
-
I-BET151 (GSK1210151A): Technical Guidance for BET Inhibitio
2026-07-27
I-BET151 (GSK1210151A) is designed for researchers investigating BET protein function, transcriptional regulation, and oncogenic pathways—especially in cancer biology and apoptosis studies. It is not suited for diagnostic or therapeutic applications, and strict adherence to storage and handling protocols is required to ensure data reproducibility.
-
Bile Acid Retention Impairs Antigen Presentation in MASH-HCC
2026-07-27
This study reveals that bile acid retention within tumor cells suppresses NLRC5-mediated MHC-I antigen presentation, enabling immune evasion in metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma (MASH-HCC). By elucidating the GPR120–bile acid–NLRC5 axis, the work identifies novel targets for restoring tumor immunogenicity and improving immunotherapy outcomes.
-
Viral Degradation of RIPK3 Modulates Necroptosis and Inflamm
2026-07-26
This study uncovers a class of orthopoxvirus proteins (vIRD) that target the necroptosis adaptor RIPK3 for ubiquitin-mediated degradation, suppressing necroptosis and reshaping the host inflammatory response. These findings reveal a mechanistic link between viral immune evasion and the SCF ubiquitin ligase complex, offering new insights into host-pathogen interactions.
-
IBDV VP3 Protein Drives IRF7 Degradation via the Proteasome
2026-07-25
This study uncovers how infectious bursal disease virus (IBDV) exploits its VP3 protein to degrade interferon regulatory factor 7 (IRF7) via the proteasome pathway, suppressing the antiviral interferon response in chicken cells. These findings reveal a previously unknown viral immune evasion mechanism with implications for poultry immunology and antiviral research.
-
Adipose-Neural Axis and NPY/Y1R in EAT-Linked Cardiac Arrhyt
2026-07-24
Fan et al. (2024) provide a mechanistic link between epicardial adipose tissue and cardiac arrhythmias, uncovering the role of the adipose-neural axis via leptin and neuropeptide Y/Y1 receptor signaling. Their stem cell-based coculture model identifies actionable molecular targets and establishes a robust experimental system for future cardiovascular and neuropeptide research.
-
Scalable iMSC-EV Production for Pulmonary Fibrosis Therapy
2026-07-24
Gong et al. introduce a robust, bioreactor-based platform for scalable production of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) from extended pluripotent stem cells (EPSCs). This innovation delivers high-yield, standardized EVs with therapeutic efficacy in a preclinical pulmonary fibrosis model, addressing key challenges of donor variability and clinical translation.
-
Polyvalent Vaccine Targets Tumor-Associated Bacteria to Halt
2026-07-23
Kang et al. present a polyvalent vaccine strategy that selectively eliminates tumor-associated bacteria, significantly impeding breast cancer metastasis in preclinical models. This innovation demonstrates the therapeutic potential of modulating the intratumoral microbiome, opening new avenues for metastasis prevention.
-
Bile Acid Retention Suppresses Antigen Presentation in MASH-
2026-07-23
This study uncovers a mechanistic axis by which bile acid retention impairs NLRC5-mediated MHC-I antigen presentation in metabolic dysfunction-associated steatohepatitis (MASH)-related hepatocellular carcinoma (HCC). The findings reveal how metabolic reprogramming enables immune evasion in MASH-HCC and highlight bile acid modulation as a promising therapeutic target for restoring tumor immunogenicity and enhancing immunotherapy efficacy.
-
TiO2-Nanoparticle SDT Prevents PCO via Ferroptosis in HLECs
2026-07-22
This study demonstrates that sonodynamic therapy (SDT) using titanium dioxide nanoparticle–coated intraocular lenses (TiO2-IOLs) effectively prevents posterior capsular opacification (PCO) by inducing ferroptosis in human lens epithelial cells (HLECs). The work provides mechanistic insight into SDT-mediated cell death and highlights potential translational strategies for ocular surgery complications.
-
Humanized Mice Advance CES Prodrug PK Assessment: Insights f
2026-07-22
This study demonstrates the pivotal role of humanized liver mice in accurately predicting human pharmacokinetics of carboxylic ester prodrugs, exemplified by HD56 targeting FK506 binding proteins. The findings refine in vivo-in vitro correlation strategies and underline the importance of model selection for translational drug development.
-
NADPH Oxidase-Derived ROS Drive Arterial Contraction via LTC
2026-07-21
This study reveals that reactive oxygen species (ROS) produced by NADPH oxidase enhance arterial contraction in early postnatal rats through activation of L-type voltage-gated Ca2+ channels (LTCC), independent of Rho-kinase, PKC, or Src kinase signaling. The findings clarify the mechanistic specificity of ROS-mediated vasomotor regulation during early vascular development and inform experimental strategies for dissecting kinase signaling pathways.
-
Repurposing Natural Compounds to Inhibit SARS-CoV-2 Protease
2026-07-21
Eskandari et al. conducted an in silico evaluation identifying several natural vitamins as potential inhibitors of the SARS-CoV-2 main protease (3CLpro) and spike protein RBD. The findings highlight the possibility of repurposing accessible compounds to disrupt viral entry and replication, informing future antiviral therapeutics research.
-
Tropifexor Mitigates PN-Induced Gut Injury in Neonatal Pigle
2026-07-20
This study demonstrates that Tropifexor (LJN452), a potent FXR agonist, significantly improves intestinal defense responses and epithelial barrier integrity in neonatal piglets subjected to parenteral nutrition. The findings provide mechanistic and transcriptomic insights, highlighting Tropifexor's translational value for pediatric metabolic and intestinal barrier research.
-
Targeting Cdc42 to Mitigate Kidney Fibrosis: Mechanistic Adv
2026-07-20
A recent study identifies the small molecule daphnepedunin A (DA) as a potent inhibitor of Cdc42-mediated signaling, effectively attenuating kidney fibrosis in cellular and animal models. By uncovering a direct link between Cdc42 inhibition and the disruption of pro-fibrotic GSK-3β/β-catenin pathways, this research provides new mechanistic and translational insights for chronic kidney disease intervention.
-
Taltirelin Inhibits Acute and Chronic Itch: Preclinical Evid
2026-07-19
A recent study demonstrates that taltirelin, a TRH analog, robustly suppresses both acute and chronic itch in murine models. These findings expand the therapeutic potential of taltirelin beyond neuroprotection, supporting its use in antipruritic research and protocol development.